Sun J, Sepulveda JL, Komissarova EV, Hills C, Seckar TD, LeFevre NM, Simonyan H, Young C, Su G, Del Portillo A, et al. CDKN2A-p16 deletion and activated KRAS drive Barrett's-like gland hyperplasia-metaplasia and synergize in the development of dysplasia pre-cancer lesions. Cell Mol Gastroenterol Hepatol. 2024.